We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns NeoMedix Over Online Promotion of Off-Label Uses
FDA Warns NeoMedix Over Online Promotion of Off-Label Uses
NeoMedix wound up in the crosshairs of FDA investigators for online claims that its Trabectome tissue removal device is effective in treating glaucoma.